Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)

The biotechnology sector is entering a dynamic growth phase, fueled by advances in gene therapy, AI-assisted drug discovery, and personalized medicine. Global biotech revenue is projected to grow from $1.55 trillion in 2024 to over $4.6 trillion by 2034, reflecting a surge in both investment and innovation. Venture funding is rebounding strongly, with billions pouring… Continue reading Discovering the Next Wave of Biotech Innovation (MDCX, RNXT, JSPR, LSB)

Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)

The biotech sector is entering a pivotal phase fueled by scientific breakthroughs, accelerated regulatory approvals, and a surge of strategic dealmaking. The Nasdaq Biotechnology Index has posted strong gains, signaling renewed investor confidence. The FDA is clearing a record number of novel therapies, while global mergers and acquisitions have climbed past $105 billion, a seven… Continue reading Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)

Medical test tubes with blood on desk in laboratory at research clinic. Biotechnology glassware, microscope and pipette as scientific equipment used for discovery in chemistry industry

Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)

After years of uncertainty, biotech is bouncing back. The Nasdaq Biotechnology Index is up over 18% year-to-date, outpacing the broader health care sector. Growth is fueled by paused interest rate hikes, record FDA approvals, and a surge in M&A activity topping $75 billion in the first half of 2025. Large pharma companies facing patent expirations… Continue reading Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)

Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)

After years of uncertainty, biotech is bouncing back. The Nasdaq Biotechnology Index is up over 18% year-to-date, outpacing the broader health care sector. Growth is fueled by paused interest rate hikes, record FDA approvals, and a surge in M&A activity topping $75 billion in the first half of 2025. Large pharma companies facing patent expirations… Continue reading Biotech’s Big Comeback: 4 Stocks Poised to Ride the Resurgence (MDCX, ARVN, RYTM, ENTA)

The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum

Over the past few months, the once-niche drone market has evolved into a compelling, investable secular story. Regulatory friction is giving way to clarity. On August 5, 2025, the U.S. Department of Transportation, alongside the FAA and TSA, unveiled a Notice of Proposed Rulemaking (NPRM) aimed at normalizing Beyond Visual Line of Sight (BVLOS) drone… Continue reading The Drone Market Is Surging as Regulation and Defense Demand Accelerate ZenaTech’s Momentum

U.S. Drone Stocks Ready for Liftoff with Groundbreaking FAA Proposal (ZENA, AVAV, KTOS, ONDS)

The race to dominate the drone economy has just entered a new phase. On August 6, 2025, U.S. Transportation Secretary Sean P. Duffy unveiled a sweeping proposal that could dramatically expand where and how drones operate in American skies. The new Beyond Visual Line of Sight (BVLOS) rule aims to remove one of the biggest… Continue reading U.S. Drone Stocks Ready for Liftoff with Groundbreaking FAA Proposal (ZENA, AVAV, KTOS, ONDS)

U.S. Drone Stocks Ready for Liftoff with Groundbreaking FAA Proposal (ZENA, AVAV, KTOS, ONDS)

The race to dominate the drone economy has just entered a new phase. On August 6, 2025, U.S. Transportation Secretary Sean P. Duffy unveiled a sweeping proposal that could dramatically expand where and how drones operate in American skies. The new Beyond Visual Line of Sight (BVLOS) rule aims to remove one of the biggest… Continue reading U.S. Drone Stocks Ready for Liftoff with Groundbreaking FAA Proposal (ZENA, AVAV, KTOS, ONDS)

Washington’s AI Push Is Accelerating: Here Are 4 Stocks Poised to Benefit (ZENA, GFS, BBAI, INOD)

Artificial intelligence is becoming an essential driver of innovation across defense, infrastructure, and enterprise technology sectors. In response, the federal government has introduced “Winning the AI Race: America’s AI Action Plan,” a comprehensive strategy to accelerate AI development, expand domestic manufacturing and data center capacity, and partner exclusively with trusted AI developers. This plan represents… Continue reading Washington’s AI Push Is Accelerating: Here Are 4 Stocks Poised to Benefit (ZENA, GFS, BBAI, INOD)

Washington’s AI Push Is Accelerating: Here Are 4 Stocks Poised to Benefit (ZENA, GFS, BBAI, INOD)

Artificial intelligence is becoming an essential driver of innovation across defense, infrastructure, and enterprise technology sectors. In response, the federal government has introduced “Winning the AI Race: America’s AI Action Plan,” a comprehensive strategy to accelerate AI development, expand domestic manufacturing and data center capacity, and partner exclusively with trusted AI developers. This plan represents… Continue reading Washington’s AI Push Is Accelerating: Here Are 4 Stocks Poised to Benefit (ZENA, GFS, BBAI, INOD)

Agriculture Goes High-Tech: Four Drones Stocks Flying High in 2025 (ZENA, UAVS, CNH, AVAV)

The agriculture drone market is exploding. Valued at 6.1 billion dollars in 2024, it is expected to nearly quadruple to 23.8 billion dollars by 2032, growing at a compound annual rate of 18.5 percent. This rapid expansion is driven by rising demand for precision farming tools that improve efficiency, reduce chemical use, and increase crop… Continue reading Agriculture Goes High-Tech: Four Drones Stocks Flying High in 2025 (ZENA, UAVS, CNH, AVAV)